Scoring | Impact factors | Clinicopathological model | Molecular model | Model comprising clinicopathological and molecular factors | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parity | Peritoneal metastasis | FIGO stage | Type | Residual disease | HER2 expression | KRAS expression | BRCA1 expression | BRAF expression | EGFR expression | ||||
0 | 0–3 | Absent | I | I | ≤0.5 cm | Low | Low | High | High | Low |  |  |  |
1 | >3 | Present | II–IV |  |  | High | High | Low | Low | High |  |  |  |
2 | Â | Â | Â | II | >0.5Â cm | Â | Â | Â | Â | Â | Â | Â | Â |
Total score | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 7 | 5 | 12 |